Today in Biology — Aug 14

[SOFIA] Welcome back to The Dish, everyone. It's Friday, and that means we're zooming through the biggest headlines shaping biology right now. And Daniel, we have to start with the Genesis Mission. It feels like every week there's a new piece of this enormous puzzle clicking into place.

[DANIEL] It does. This week, we saw NIST, the National Institute of Standards and Technology, officially join the Genesis Mission, which is DOE's massive push for AI in science. And it wasn't just an announcement; the inaugural Genesis Mission Summit just wrapped up, highlighting 278 projects already underway.

[SOFIA] 278 projects! That's a huge number. And we're also seeing the DOE launching an Open Model Initiative as part of Genesis, aiming to create open-weight foundation models specifically for scientific discovery. So for everyone listening, this isn't just about applying existing AI tools to science; it's about building entirely new AI from the ground up, designed to accelerate research in fields from materials science to biology.

[DANIEL] Exactly. And NIST's involvement is key because they bring that focus on measurement science, data integrity, and establishing standards, which is absolutely critical if these AI models are going to be robust and trustworthy for scientific applications. Without that rigor, the output of even the most powerful AI is just noise.

[SOFIA] Right, it’s not enough to just *have* big models; they need to be trained on good data and evaluated rigorously. For engineering biology, this could be massive. Imagine AI that can rapidly design new enzymes, predict protein folding under novel conditions, or even optimize entire metabolic pathways for non-model organisms without us having to run thousands of experiments. This initiative is laying the groundwork for that kind of accelerated discovery.

[DANIEL] It's ambitious. Shifting gears a bit, something else that caught my eye was the news from NIH. *Nature* reported this week that the NIH is limiting funding for research where the primary function is informing public policy.

[SOFIA] Yeah, that one definitely sparked some conversation. Apparently, they've started turning away grant applications that focus primarily on that policy-informing aspect. Now, they say they’re on track to spend their full grants budget by September 30th, which is good news for overall funding levels, but this specific policy shift is… interesting.

[DANIEL] "Interesting" is one word for it. It raises questions about the perceived boundary between basic research and its societal application. While the NIH's core mission is health research, the implications of that research often extend directly into public health policy. If funding for studies explicitly designed to inform policy is curtailed, it could create a gap in how we translate scientific findings into actionable public health strategies. It's a subtle but potentially significant shift in emphasis.

[SOFIA] And it contrasts a bit with some of the broader pushes we see for science to directly impact society. It’ll be important to watch how this plays out for fields like public health genomics or environmental health sciences, where policy implications are often front and center.

[SOFIA] And finally, a brief but impactful note: the Department of Justice declared three race-based STEM programs unconstitutional. These programs involved about $104 million in federal funds just last year, aimed at diversifying STEM fields.

[DANIEL] Yes, this decision could have significant ripples across initiatives designed to broaden participation in science and engineering. It forces a re-evaluation of how diversity goals are pursued within federal funding structures, and it’s a conversation that hits very close to home for many in the scientific community.

[SOFIA] Absolutely. These are critical programs for building a more inclusive and representative scientific workforce. It’ll be a space to watch very closely. And that’s our quick spin through the biggest news in biology this week. Thanks for joining us, Daniel.

[DANIEL] My pleasure, Sofia.